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The primary structure of the chymotrypsin hibitor (SCI-III), from larvae of the silkworm, Bombyx mori, 
has been determined. This inhibitor seems to be a Kunitz-type inhibitor judging from the sequence 
homology with the bovine basic pancreatic trypsin inhibitor, but has one more amino acid in the half- 
cystine frame nearest the N-terminus. The amino acid at the deduced reactive site (PI) is phenylalanine 
and this inhibitor is the first example of the Kunitz type that is assigned phenylalanine to its reactive site. 
Proteinase inhibitor Chymotrypsin Amino acid sequence Specificity Binding region 
1. INTRODUCTION the primary inhibitor-proteinase binding site. 
Here, the primary structure of SCI-III is described. 
It is well known that protein proteinase in- 
hibitors are widely distributed among animals, 
plants and bacteria and they are thought to play an 
important role in regulating the activities of pro- 
teinases in vivo. Accumulation of primary struc- 
ture data about these inhibitors has revealed the 
existence of several homologous structures bet- 
ween some inhibitors [ 11. Kunitz-type inhibitor, 
one of these groups, is based on the frame struc- 
ture of 6 half-cystine residues of bovine basic pan- 
creatic trypsin inhibitor (BPTI) [2]. This group in- 
cludes inhibitors isolated from bovine colostrum 
[3], snail [4], and several snake venoms [5-81. We 
have reported the isolation and characterization of 
3 low-M, (7000) chymotrypsin inhibitors from 
hemolymph of the silkworm larvae, Bombyx mori. 
Two (SCI-I and -11) are basic, one (SCI-III) is an 
acidic protein and they have similar amino acid 
compositions except for charged amino acid con- 
tents. These inhibitors are rare ones isolated from 
insect and can inhibit only chymotrypsin at a 1: 1 
molar ratio. Elucidation of their covalent structure 
is necessary for comparison with those of other 
species and for estimation of the reactive site, or 
2. MATERIALS AND METHODS 
The isolation procedure of SCI-III was as in [9] 
except for the use of SP-Sephadex C-25 at pH 3.0 
instead of chymotrypsin-Sepharose 4B. The S- 
carboxymethylation was also according to [9]. 
Tryptic digestion of S-carboxymethylated SCI-III 
(SCM-SCI-III) was carried out at 100: 1 (w/w) 
substrate : enzyme in 0.1 M Nl&HCO3 (pH 8.0) at 
35°C for 4 h. Peptides were separated on a Dowex 
50-X2 column using a gradient of pyridine-acetate 
buffer from 0.2 M (pH 3.1) to 2 M (pH 5.0) [lo]. 
Detection of peptides was performed by ninhydrin 
reaction after alkaline hydrolysis. 
Chymotryptic digestion of SCM-SCI-III was 
carried out at 100: 1 (w/w) substrate : enzyme in 
0.1 M NH4HCOs (pH 8.0) at 25°C for 30 min. 
Peptides were separated on DEAE-Sephadex A-25 
using a linear gradient of NH4HCOs from 0.01 to 
1 M and were detected by the absorbance at 
230 nm. 
Digestion of SCM-SCI-III by Staphylococcus 
aureus V8 protease was carried out at 25 : 1 (w/w) 
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substrate: enzyme in 0.05 M NH4HCO3 (pH 7.8) 
at 35°C for 24 h. Peptides were separated by high- 
performance liquid chromatography (HPLC) with 
a Jasco Finepak SIL Cis column as in [ll]. 
Chymotryptic subfragments were generated in 
0.1 M NH4HCO3 (pH 8.0) (peptide :enzyme, 30 : 1) 
at 35°C for 2 h and peptides were also separated as 
in [ll]. 
Amino acid analyses of peptides were performed 
with a Jeol JLC-8AH amino acid analyzer after 
hydrolysis in 6 N HCl at 110°C for 22 h. 
Automated sequence analyses were performed 
with a Jeol JAS-47K sequence analyzer according 
to the manufacturer’s manual using 0.25 M 
Quadrol buffer as a coupling buffer. Manual se- 
quence analyses were carried out as in [12]. 
Phenylthiohydantoin amino acid derivatives were 
identified by HPLC as in [13]. 
3. RESULTS AND DISCUSSION 
The complete amino acid sequence of silkworm 
chymotrypsin inhibitor (SCI-III) is shown in fig.1 
together with the key peptides used for sequence 
elucidation. This inhibitor consists of 63 amino 
acid residues and has 6 half-cystine residues at 
positions 10, 20, 36, 44, 57 and 61 from the N- 
terminus. This arrangement closely resembles that 
of the so-called Kunitz-type inhibitor, but differs 
1 5 10 
in only one respect, i.e., the half-cystine frame 
nearest the N-terminus contains 9 amino acid 
residues instead of 8 (fig.2). Other highly con- 
served amino acids in Kunitz-type inhibitor, such 
as Gly-12, Tyr-23, Asn-24, Phe-33, Tyr-35, Gly-36, 
Gly-37, Asn-43 and Phe-45 (numbered according 
to BPTI), which are thought to be in contact with 
the amino acids of proteinase on binding [ 141, also 
exist in SCI-III at the same positions (fig.2). 
Though the arrangement of half-cystine defines 
the Kunitz-type inhibitor, we believe SCI-III to 
belong to this group because the arrangement of 
key amino acids to be preserved, other than that of 
the half-cystine nearest he N-terminus, agrees well 
with that of Kunitz-type inhibitor. Estimation of 
excessively inserted amino acid within the half- 
cystine frame nearest he N-terminus of SCI-III is 
not easy because the conservation of amino acids 
in this region is not so rigid in Kunitz-type in- 
hibitor. The effect of insertion on inhibiting 
capacity is not obvious, but judging from the 
magnitude of the dissociation constant (Ki z 
10m8 M) [9] and from the contact region profile 
deduced from crystallographical analysis of 
BPTI-trypsin complex [ 141, a serious defect as an 
inhibitor does not seem to result from the inser- 
tion. In any case, this is the first example of find- 
ing the discrepancy of the half-cystine frame in 
Kunitz-type inhibitor. 
15 20 
25 30 35 40 
Gly-Tyr-Met-Lys-Leu-Tyr-Ser-Tyr-Asn-Gln-Glu-Thr-Lys-Asn-Cys-Glu-Glu-Phe-Ile-Tyr-Gly- 
+-_j--+*++ 
-Tl~ T2 
l--1---------1 t_st1- t 
45 50 55 60 63 
Gly-Cys-Gln-Gly-Asn-Asp-Asn-Arg-Phe-Ser-Thr-Leu-Ala-Glu-Cys-Glu-Gln-Lys-Cys-Ile-Asn 
1aT3~, 
I c2 I 
st2-cl'~st2-C2----i 
Fig. 1. Amino acid sequence of silkworm chymotrypsin inhibitor, SCI-III: Tl-T3, tryptic peptides of SCM-SCI-III; Cl 
and C2, chymotryptic peptides of SCM-SCI-III; St1 and St2, S. at4reu.s V8 fragments of SCM-SCI-III; StZCl and 
St2-C2, chymotryptic peptides of St2; ( d) sequence analyzer run of SCM-SCI-III. Only the overlapping key peptides 
are shown. 
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5 10 15 20 25 30 35 
PDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVY 
PICEQAFGDAGLCFGYMKLYSYNQETKNCEEFIY 
PDLCQLPQARGPCKAALLRYFYNSTSNACEPFTY 
PSFCNLPAETGPCKASFRQYYYNSKSGGCQQFIY 
I 
PRFCELPAETGLCKARIRSFHYNRAAQQCLEFIY 
PTFCNLAPESGRCRGHLRRIYYNLESNKCEVFFY 
PKFCYLPADPGRCLAYMPRFYYNPASNKCEKFIY 
40 45 50 55 60 
GCRAKRNNFKSAEDCMRTCGGA 
GCQGNDNRFSTLAECEQKCIN 
GCQGNNNNFETTEMCLRICEPPQQTDKS 
GCRGNQNRFDTTQQCQGVCV 
GCGGNANRFKTIDECHRTCVG 
GCGGNANNFETRDECRETCGGK 
GCRGNANNFKTWDECRHTCVASGIQPR 
Fig.2. Comparison of the amino acid sequence of silkworm chymotrypsin inhibitor, SCI-III, with the sequences of 
Kunitz-type inhibitors. Numbering of residues is according to BPTI. Inhibitors: (a) BPTI [2], (b) SCI-III [here], (c) 
bovine colostrum trypsin inhibitor [3], (d) snail (Helixpomatia) trypsin inhibitor K [4], (e) snake venom, iVaja nivea 
NNV-II [5], (f) snake venom, Vipera russelli II [6], (g) snake venom, Viperu ammodytes [7]. Residues enclosed within 
a rectangle correspond to Pi residue [15]. 
The amino acid corresponding to the reactive 
site (Pr) [15] of SCI-III which defines the specifici- 
ty of inhibitor primarily is deduced as 
phenylalanine from the established position of the 
reactive site (PI) in the Kunitz-type inhibitor 
(fig.2). Though the attempts to obtain a reactive 
site cleaved XI-III have thus far been unsuc- 
cessful, the estimated reactive site residue, 
phenylalanine, can satisfy the cleavage site 
specificity of chymotrypsin. A Kunitz-type in- 
hibitor having phenylalanine as a reactive site 
amino acid (PI) has not been found. Recently, 
authors in [7] elucidated the primary structure of 
Kunitz-type chymotrypsin inhibitor from Vipera 
ammodytes venom and found its reactive site (Pr) 
to be leucine. This venom inhibitor and silkworm 
inhibitor, SCI-III, can inhibit chymotrypsin with 
dissociation constants Ki = 4.3 x lb-’ M and 
Ki = 1.3 x lo-* M, respectively. The difference in 
the reactive site amino acid, leucine and 
phenylalanine, apparently has little effect on bind- 
ing capacities. 
Elucidation of the primary structure of other 
silkworm chymotrypsin inhibitors, SCI-I and SCI- 
II, is now in progress, and it is found that they also 
have phenylalanine at the expected reactive site 
(PI) and have one more excessively inserted amino 
acid in the half-cystine frame nearest the N- 
terminus. 
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